Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
41
OMER Quote, Financials, Valuation and Earnings
Last price:
$15.38
Seasonality move
:
17.3%
Day range:
$13.92 - $17.65
52-week range:
$2.95 - $17.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
24.5M
Avg. volume:
2.6M
1-year change:
53.6%
Market cap:
$1.1B
Revenue:
--
EPS (TTM):
-$2.02
Analysts' Opinion
-
Consensus RatingOmeros Corp. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 2 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $28.00, Omeros Corp. has an estimated upside of 82.29% from its current price of $15.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $20.00 representing -30.21% downside risk from its current price of $15.36.
Fair Value
-
According to the consensus of 4 analysts, Omeros Corp. has 82.29% upside to fair value with a price target of $28.00 per share.
OMER vs. S&P 500
-
Over the past 5 trading days, Omeros Corp. has overperformed the S&P 500 by 71.5% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Omeros Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Omeros Corp. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Omeros Corp. reported revenues of --.
Earnings Growth
-
Omeros Corp. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Omeros Corp. reported earnings per share of -$0.47.
Enterprise value:
1.4B
EV / Invested capital:
9.91x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
-0.08x
EV / Free cash flow:
-13.45x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$1M
Return On Assets:
-50.02%
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
-59.56%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$846K | -$854K | -$1M | -$237K | -$240K | |
| Operating Income | -$164.9M | -$173.4M | -$129.4M | -$35.4M | -$26.4M | |
| EBITDA | -$164.1M | -$172.5M | -$128.3M | -$35.2M | -$26.2M | |
| Diluted EPS | $0.32 | -$2.30 | -$2.02 | -$0.56 | -$0.47 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $91.3M | $288.5M | $351.3M | $164.9M | $71.8M | |
| Total Assets | $123.4M | $457.6M | $493.1M | $313.3M | $185.7M | |
| Current Liabilities | $42.8M | $39.5M | $147.2M | $55.6M | $80.8M | |
| Total Liabilities | $386.1M | $503.9M | $507M | $467.5M | $406.2M | |
| Total Equity | -$262.7M | -$46.3M | -$14M | -$154.2M | -$220.5M | |
| Total Debt | $348.4M | $467.8M | $466.3M | $433.4M | $363.4M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $84.2M | -$154.6M | -$105.2M | -$32.1M | -$18.5M | |
| Cash From Investing | -$197.3M | $163.5M | $87.9M | $36M | -$6.9M | |
| Cash From Financing | -$1.8M | -$38M | $18.2M | -$4.6M | $25.8M | |
| Free Cash Flow | $83.8M | -$154.9M | -$105.3M | -$32.1M | -$18.5M | |
OMER
Sector
Market Cap
$1.1B
$28.1M
Price % of 52-Week High
87.03%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
-7.05%
-1.49%
1-Year Price Total Return
53.6%
-17.13%
Beta (5-Year)
2.485
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$9.90
200-day SMA
Buy
Level
$5.84
Bollinger Bands (100)
Buy
Level
3.94 - 9.12
Chaikin Money Flow
Sell
Level
-36.7M
20-day SMA
Buy
Level
$10.25
Relative Strength Index (RSI14)
Buy
Level
75.26
ADX Line
Buy
Level
31.77
Williams %R
Neutral
Level
-24.4136
50-day SMA
Buy
Level
$8.83
MACD (12, 26)
Buy
Level
0.71
25-day Aroon Oscillator
Buy
Level
88
On Balance Volume
Neutral
Level
127.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-5.6306)
Sell
CA Score
(Annual)
Level (-6.5445)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (9.9594)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Stock Forecast FAQ
In the current month, OMER has received 2 Buy ratings 2 Hold ratings, and 0 Sell ratings. The OMER average analyst price target in the past 3 months is $28.00.
-
Where Will Omeros Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Omeros Corp. share price will rise to $28.00 per share over the next 12 months.
-
What Do Analysts Say About Omeros Corp.?
Analysts are divided on their view about Omeros Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Omeros Corp. is a Sell and believe this share price will drop from its current level to $20.00.
-
What Is Omeros Corp.'s Price Target?
The price target for Omeros Corp. over the next 1-year time period is forecast to be $28.00 according to 4 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is OMER A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Omeros Corp. is a Leans Bullish. 2 of 4 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of OMER?
You can purchase shares of Omeros Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Omeros Corp. shares.
-
What Is The Omeros Corp. Share Price Today?
Omeros Corp. was last trading at $15.38 per share. This represents the most recent stock quote for Omeros Corp.. Yesterday, Omeros Corp. closed at $15.36 per share.
-
How To Buy Omeros Corp. Stock Online?
In order to purchase Omeros Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get OMER Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OMER
Sector
P/E ratio
--
23.89x
PEG ratio
-0.08x
-0.01x
P/B ratio
--
1.81x
Price / LTM sales
--
1.59x
Growth Metrics
OMER
Sector
Revenue growth
--
4.62%
Earnings growth
16.11%
11.06%
Revenue (5-year growth)
-100%
6.5%
Earnings forecast
-$0.48
-$0.21
Profitability
OMER
Sector
Profitability FY 2024
-$950K
$3.6M
Return on invested capital
-59.56%
-31.84%
Return on assets
-50.02%
-27.96%
Return on equity
--
-37.63%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Mar
31
Estimated Next Earnings Date
Feb
12
Balance Sheet
OMER
Sector
Total cash
$36.1M
$26.4M
Short term investments
$86.7M
$25.7M
Total assets
$277.1M
$76.9M
Long term debt
$363.4M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
87
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
60
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
